Lee EK - Search Results

1

Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.

Lee EK, Herr HW, Dickstein RJ, Kassouf W, Munsell MF, Grossman HB, Dinney CP, Kamat AM. Lee EK, et al. BJU Int. 2012 Dec;110(11 Pt B):E590-5. doi: 10.1111/j.1464-410X.2012.11325.x. Epub 2012 Jul 3. BJU Int. 2012. PMID: 22758775 Clinical Trial.

2

Imaging of urothelial cancers: what the urologist needs to know.

Lee EK, Dickstein RJ, Kamta AM. Lee EK, et al. AJR Am J Roentgenol. 2011 Jun;196(6):1249-54. doi: 10.2214/AJR.10.6232. AJR Am J Roentgenol. 2011. PMID: 21606285 Review.

3

Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo.

Jinesh GG, Lee EK, Tran J, Kamat AM. Jinesh GG, et al. Among authors: lee ek. Urol Oncol. 2013 Nov;31(8):1676-1682. doi: 10.1016/j.urolonc.2012.05.007. Epub 2012 Jun 19. Urol Oncol. 2013. PMID: 22717623 Free PMC article.

4

Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis.

Jinesh GG, Choi W, Shah JB, Lee EK, Willis DL, Kamat AM. Jinesh GG, et al. Among authors: lee ek. Cell Death Differ. 2013 Mar;20(3):382-95. doi: 10.1038/cdd.2012.140. Epub 2012 Nov 23. Cell Death Differ. 2013. PMID: 23175184 Free PMC article.

5

Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer.

Lee EK, Ye Y, Kamat AM, Wu X. Lee EK, et al. Cancer. 2013 May 1;119(9):1643-51. doi: 10.1002/cncr.27871. Epub 2013 Mar 25. Cancer. 2013. PMID: 23529717 Free PMC article.

6

A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin.

Lee EK, Jinesh G G, Laing NM, Choi W, McConkey DJ, Kamat AM. Lee EK, et al. Cancer Biol Ther. 2013 Sep;14(9):812-22. doi: 10.4161/cbt.25326. Epub 2013 Jun 19. Cancer Biol Ther. 2013. PMID: 23792592 Free PMC article.

7

The effect of concomitant carcinoma in situ on neoadjuvant chemotherapy for urothelial cell carcinoma of the bladder: inferior pathological outcomes but no effect on survival.

Parker WP, Ho PL, Melquist JJ, Scott K, Holzbeierlein JM, Lopez-Corona E, Kamat AM, Lee EK. Parker WP, et al. Among authors: lee ek. J Urol. 2015 May;193(5):1494-9. doi: 10.1016/j.juro.2014.11.003. Epub 2014 Nov 11. J Urol. 2015. PMID: 25451834

8

The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.

Parker WP, Ho PL, Boorjian SA, Melquist JJ, Thapa P, Holzbeierlein JM, Frank I, Kamat AM, Lee EK. Parker WP, et al. Among authors: lee ek. World J Urol. 2016 Nov;34(11):1561-1566. doi: 10.1007/s00345-016-1801-y. Epub 2016 Mar 4. World J Urol. 2016. PMID: 26943643

9

Should we care more about SPARE?

Lee EK, Kamat AM. Lee EK, et al. BJU Int. 2017 Nov;120(5):605-606. doi: 10.1111/bju.13953. BJU Int. 2017. PMID: 29035018 No abstract available.

10

Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer.

Williams SB, Hudgins HK, Ray-Zack MD, Chamie K, Smaldone MC, Boorjian SA, Daneshmand S, Black PC, Kamat AM, Goebell PJ, Seiler R, Schmitz-Drager B, Nawroth R, Baillargeon J, Klaassen Z, Kulkarni GS, Kim SP, Lee EK, Holzbeierlein JM, Hollenbeck BK, Gore JL. Williams SB, et al. Among authors: lee ek. Eur Urol Oncol. 2019 Mar;2(2):119-125. doi: 10.1016/j.euo.2018.07.006. Epub 2018 Aug 14. Eur Urol Oncol. 2019. PMID: 31017086 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,400 results

Search Page